BREAST ADENOCARCINOMA
Clinical trials for BREAST ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BREAST ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a new combo drug slow advanced breast cancer?
Disease control OngoingThis phase 3 trial tested whether adding the drug entinostat to standard hormone therapy (exemestane) helps people with advanced hormone receptor-positive breast cancer live longer without their cancer growing. The study included 608 adults whose breast cancer had spread locally …
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Can a blood flow blocker boost chemo for aggressive breast cancer?
Disease control OngoingThis study looked at nearly 5,000 people with breast cancer that had spread to lymph nodes or was at high risk of returning. They received standard chemotherapy (doxorubicin, cyclophosphamide, and paclitaxel) plus either bevacizumab (a drug that cuts off tumor blood supply) or a …
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
Triple-Drug attack on Hard-to-Treat cancers shows early promise
Disease control OngoingThis early-phase study tests the safety and best doses of three drugs—entinostat, nivolumab, and ipilimumab—given together to people with advanced solid tumors that have spread or cannot be removed by surgery. The goal is to see if this combination can help the immune system figh…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New radiation schedule aims to cut arm swelling in breast cancer patients
Disease control OngoingThis study tested a shorter course of radiation (hypofractionation) to the breast and nearby lymph nodes in 137 women with node-positive breast cancer. The goal was to see if this approach reduces long-term side effects like arm swelling (lymphedema) while still controlling cance…
Matched conditions: BREAST ADENOCARCINOMA
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Landmark study finds many breast cancer patients can skip chemo
Disease control OngoingThis large study looked at over 10,000 women with early-stage, hormone-receptor-positive breast cancer that hasn't spread to lymph nodes. It used a genetic test (Oncotype DX) to see who could safely skip chemotherapy and just take hormone therapy. The goal was to find the best tr…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Immune booster before chemo shows promise for tough breast cancers
Disease control OngoingThis study tests whether giving two immunotherapy drugs (decitabine and pembrolizumab) before standard chemotherapy can increase immune cell activity in breast tumors. It involves 46 people with locally advanced HER2-negative breast cancer, divided by hormone receptor status. The…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Proton beam therapy aims to improve breast cancer treatment results
Symptom relief OngoingThis study looks at how well proton beam radiation works for women with early-stage breast cancer (stages 0 to II). The goal is to see if this type of radiation can kill cancer cells while causing fewer side effects and better cosmetic results compared to standard radiation. Abou…
Matched conditions: BREAST ADENOCARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
New study aims to close breast cancer knowledge gap for transgender individuals
Knowledge-focused OngoingThis study gathers information from multiple hospitals about breast cancer in transgender and gender-diverse (TGD) adults. Researchers will look at how the cancer was found, what risk factors were present, what treatments were used, and how well patients did over time. The goal i…
Matched conditions: BREAST ADENOCARCINOMA
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 13, 2026 16:01 UTC